Answers are grounded in this paper and cite their sources.
Urine cytology is an indispensable test for detecting high-grade urothelial carcinoma (HGUC); however, the distinction between HGUC cells and morphologically similar benign atypical cells poses clinical challenges. In this study, we performed double immunostaining for p53 and vimentin to establish a diagnostic method to accurately distinguish HGUC cells from benign atypical cells.
No takes yet. Share an insight, caveat, or question.
Ose et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: